Citalopram Overdose,Serotonin Toxicity,or Neuroleptic Malignant Syndrome?

Aydin N Anac E Caykoylu A Akcay F. Neuroleptic malignant syndrome due to citalopram. Can J Psychiatry 2000;45:941–2.

Velamoor VR . Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Saf 1998;19:73–82.

Lane R Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: Review. J Clin Psychopharmacol 1997;17:208–21.

Gillman PK . Serotonin syndrome: History and risk. Fundam Clin Pharmacol 1998;12:482–91.

Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705–13.

Gillman PK . The serotonin syndrome and its treatment. J Psychopharmacol 1999;13:100–9.

Whyte I. Serotonin syndrome complicating treatment of recurrent depression. Current Therapeutics 1999;40:6–7.

Nisijima K Yoshino T Yui K Katoh S. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001;890:23–31.

Fischer P. Serotonin syndrome in the elderly after antidepressive monotherapy. J Clin Psychopharmacol 1995;15:440–2.